$OHI

Omega Healthcare Investors (NYSE:OHI) Given New $47.00 Price Target at Scotiabank

Scotiabank cut its price target for Omega Healthcare Investors (NYSE:OHI) to $47 from $50 and kept a “sector perform” rating, implying 5.65% upside from the prior close, according to Benzinga. Other firms issued mixed targets: RBC raised to $48, Truist lowered to $46, Wells Fargo to $49, and BofA reiterated $46. OHI last reported $0.47 EPS and $322.96M revenue for Q1.

Original reporting
Published Jun 18, 2026, 3:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 3:54 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Omega Healthcare Investors (NYSE:OHI) Given New $47.00 Price Target at Scotiabank — source image
Decision brief

The 30-second read

$OHINeutralLow
01

Why it matters

A single-broker PT reduction is a modest sentiment input; without a new fundamental disclosure, it is unlikely to drive a large repricing by itself.

02

Market read

Traders may treat this as a small, near-term sentiment adjustment rather than a catalyst, given the lack of new operational/regulatory information.

03

What to watch

The article also cites recent earnings (EPS miss vs consensus) and FY 2026 EPS guidance, which may dominate price action versus incremental PT tweaks.

Relevance 4/10Novelty 4/10Timing: Thursday research-note update (midday trading context)

Background

The piece reports a Scotiabank research-note update on Omega Healthcare Investors’ valuation target, alongside other sell-side PT/rating updates and recent trading/earnings context.

Company-level read

Ticker impact

$OHINeutralMedium confidence
Context

Scotiabank cut Omega Healthcare Investors’ price target to $47 from $50 while keeping a “sector perform” rating, implying revised valuation expectations.

Expected impact

Likely limited, sentiment-driven drift rather than a fundamental repricing.

Evidence & confidence

The article discloses a specific PT reduction ($50→$47) with no change to the stated rating, and no new company-specific operational/regulatory catalyst.

Market effects

Minor read-through for healthcare REIT valuation sentiment; multiple banks show mixed PT changes and mostly “perform/hold” stances.

None indicated.

None indicated.

Counterpoint

Because the rating stays “sector perform” and other banks’ targets are clustered ($46–$49), the PT cut may not materially change consensus risk/reward.

Key entities

  • Omega Healthcare Investors

    Healthcare REIT; Scotiabank lowered its price target to $47 from $50 while maintaining a “sector perform” rating.

Related articles

$OHIMed

Omega Healthcare Investors (OHI) Q2 2026 Earnings Call Transcript

Omega Healthcare Investors (OHI) discussed its Q2 2026 earnings call, focusing on portfolio resilience in skilled nursing and senior housing and capital allocation. It reported Q1 adjusted FFO of $0.83 per share and FAD of $0.78, flat sequentially due to $563 million asset sales. OHI cited 6.7% cap-rate dispositions, operator EBITDAR coverage of 1.65x (as of Mar 31, 2026), a $16 million DIP paydown, and a $480 million CommuniCare asset exit.

$OHIMed

Omega Healthcare Investors Q2 Earnings Call Highlights

Omega Healthcare Investors (OHI) reported Q2 adjusted funds from operations (AFFO) of $261 million, or $0.83/share, and FAD of $248 million, or $0.78/share. The company completed $377 million in new investments and used about $700 million in asset-sale proceeds and loan repayments to cut revolver borrowings to $6 million. OHI raised 2026 AFFO guidance to $3.22-$3.26/share and expects a temporary earnings headwind from late Q2 closings.

$OHIMed

OMEGA HEALTHCARE INVESTORS INC (OHI): Results of Operations and Financial Condition

OMEGA HEALTHCARE INVESTORS INC (OHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ohi-20260729xex99d1.htm EX-99.1 Exhibit 99.1 ​ 303 International Circle P : 410.427.1700 Suite 200 Hunt Valley, MD 21030 ​ PRESS RELEASE – FOR IMMEDIATE RELEASE OMEGA REPORTS SECOND QUARTER 2026 RESULTS AND RECENT DEVELOPMENTS Completed $126 Million in New Investments i

$GOODHighAI 9/10

F&P Healthcare weighs on NZX50 ahead of earnings

New Zealand’s S&P/NZX 50 fell 0.2% to 12,970.28 as exporters and property stocks were broadly weaker ahead of Fisher & Paykel Healthcare’s annual earnings on Tuesday and Goodman New Zealand’s results. F&P shares slipped 1.3% to $33.66. Oceania Healthcare rose 2.8% after brokers lifted targets. Outside the index, Pacific Edge gained 3.7% while Eroad fell 8% after missing guidance; Ampfield seeks board control.

$SUNEMedAI 8/10

Pentagon to invest $400m in Australian rare earth mine

Sunrise Energy Metals said the US Pentagon will provide a conditional $400 million loan commitment to develop Syerston, a proposed scandium mine in Fifield, NSW. The project targets Western supply of scandium used in defence and other sectors amid China’s export restrictions. Sunrise also said it has a deal with Lockheed Martin for 25% of output for five years.

$NVDAMed

Nvidia to Invest Up to $3 Billion in Blackstone

The Information reported Nvidia plans to invest up to $3 billion in Lancium, a Blackstone-backed power and data center infrastructure developer tied to the Stargate AI initiative. Nvidia would initially put in $2 billion for a 20% stake, with up to $1 billion more contingent on performance thresholds. No company comment was provided.